EIF2AK3 variants in Dutch patients with Alzheimer's disease
Tsz Hang Wong (Erasmus MC)
Sven J. van der Lee (Erasmus MC)
Jeroen G.J. van Rooij (Erasmus MC)
Lieke H.H. Meeter (Erasmus MC)
Petra Frick (German Center for Neurodegenerative Diseases (DZNE))
Shamiram Melhem (Erasmus MC)
Harro Seelaar (Erasmus MC)
M. Arfan Ikram (Erasmus MC)
Henne Holstege (Amsterdam UMC)
Marc Hulsman (TU Delft - Electrical Engineering, Mathematics and Computer Science, Amsterdam UMC)
undefined More Authors (External organisation)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Next-generation sequencing has contributed to our understanding of the genetics of Alzheimer's disease (AD) and has explained a substantial part of the missing heritability of familial AD. We sequenced 19 exomes from 8 Dutch families with a high AD burden and identified EIF2AK3, encoding for protein kinase RNA-like endoplasmic reticulum kinase (PERK), as a candidate gene. Gene-based burden analysis in a Dutch AD exome cohort containing 547 cases and 1070 controls showed a significant association of EIF2AK3 with AD (OR 1.84 [95% CI 1.07–3.17], p-value 0.03), mainly driven by the variant p.R240H. Genotyping of this variant in an additional cohort from the Rotterdam Study showed a trend toward association with AD (p-value 0.1). Immunohistochemical staining with pPERK and peIF2α of 3 EIF2AK3 AD carriers showed an increase in hippocampal neuronal cells expressing these proteins compared with nondemented controls, but no difference was observed in AD noncarriers. This study suggests that rare variants in EIF2AK3 may be associated with disease risk in AD.
help_outline